Bd to invest $35 million in nebraska facility to expand prefilled flush syringe manufacturing to support u.s. health care

Franklin lakes, n.j. , aug. 4, 2025 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its columbus, neb.
BDX Ratings Summary
BDX Quant Ranking